Anu Osinusi

21.8k total citations
86 papers, 2.0k citations indexed

About

Anu Osinusi is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Anu Osinusi has authored 86 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Hepatology, 40 papers in Epidemiology and 31 papers in Infectious Diseases. Recurrent topics in Anu Osinusi's work include Hepatitis C virus research (67 papers), Liver Disease Diagnosis and Treatment (30 papers) and Hepatitis B Virus Studies (30 papers). Anu Osinusi is often cited by papers focused on Hepatitis C virus research (67 papers), Liver Disease Diagnosis and Treatment (30 papers) and Hepatitis B Virus Studies (30 papers). Anu Osinusi collaborates with scholars based in United States, Germany and United Kingdom. Anu Osinusi's co-authors include Shyam Kottilil, Henry Masur, John G. McHutchison, Diana M. Brainard, Anita Kohli, Michael A. Polis, Amy Nelson, Zayani Sims, Anita Mathias and Eric G. Meissner and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Anu Osinusi

80 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anu Osinusi United States	23	1.6k	1.4k	618	137	122	86	2.0k
Holger Hinrichsen Germany	24	2.3k 1.5×	2.1k 1.5×	398 0.6×	268 2.0×	148 1.2×	111	2.9k
Małgorzata Pawłowska Poland	21	696 0.4×	767 0.6×	398 0.6×	72 0.5×	90 0.7×	123	1.4k
Alejandro Soza Chile	21	968 0.6×	1.6k 1.2×	261 0.4×	83 0.6×	71 0.6×	66	2.2k
Benjamin Maasoumy Germany	25	1.7k 1.1×	1.5k 1.1×	305 0.5×	76 0.6×	120 1.0×	140	2.1k
Obaid S. Shaikh United States	25	1.0k 0.7×	1.0k 0.7×	368 0.6×	44 0.3×	39 0.3×	63	1.7k
Johannes Wiegand Germany	29	1.8k 1.1×	1.9k 1.4×	271 0.4×	116 0.8×	323 2.6×	132	2.6k
Sabela Lens Spain	26	2.4k 1.5×	2.1k 1.6×	237 0.4×	155 1.1×	95 0.8×	119	2.7k
Giorgio Barbarini Italy	31	963 0.6×	1.4k 1.0×	762 1.2×	152 1.1×	102 0.8×	88	2.5k
Gonzalo Crespo Spain	22	1.6k 1.0×	1.7k 1.2×	205 0.3×	54 0.4×	60 0.5×	90	2.3k
Lisa D. Pedicone United States	20	2.1k 1.3×	3.0k 2.2×	1.5k 2.5×	234 1.7×	78 0.6×	56	3.5k

Countries citing papers authored by Anu Osinusi

Since Specialization

Citations

This map shows the geographic impact of Anu Osinusi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anu Osinusi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anu Osinusi more than expected).

Fields of papers citing papers by Anu Osinusi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anu Osinusi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anu Osinusi. The network helps show where Anu Osinusi may publish in the future.

Co-authorship network of co-authors of Anu Osinusi

This figure shows the co-authorship network connecting the top 25 collaborators of Anu Osinusi. A scholar is included among the top collaborators of Anu Osinusi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anu Osinusi. Anu Osinusi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Buti, Marı́a, Heiner Wedemeyer, Soo Aleman, et al.. (2024). Patient-reported outcomes in chronic hepatitis delta: An exploratory analysis of the phase III MYR301 trial of bulevirtide. Journal of Hepatology. 82(1). 28–36. 7 indexed citations

Asselah, Tarik, Pietro Lampertico, Soo Aleman, et al.. (2024). Bulevirtide Monotherapy Is Safe and Well Tolerated in Chronic Hepatitis Delta: An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 48. Liver International. 45(4). e16174–e16174. 5 indexed citations

Humeniuk, Rita, Kavita Juneja, Shuguang Chen, et al.. (2023). Pharmacokinetics, safety, and tolerability of inhaled remdesivir in healthy participants. Clinical and Translational Science. 16(11). 2276–2288. 5 indexed citations

Jacobson, Ira M., Stefan Bourgeois, Paul J. Thuluvath, et al.. (2023). The tolerability of sofosbuvir/velpatasvir for 12 weeks in patients treated in the ASTRAL 1, 2 and 3 studies: A pooled safety analysis. Journal of Viral Hepatitis. 30(5). 448–454. 1 indexed citations

Buti, Marı́a, Heiner Wedemeyer, Soo Aleman, et al.. (2023). Treatment with Bulevirtide Improves Patient-reported Outcomes in Patients with Chronic Hepatitis Delta: An Exploratory Analysis of a Phase 3 Trial at 48 Weeks. Zeitschrift für Gastroenterologie. 61(1). e47–e47.

Brown, Samuel M., Morgan J. Katz, Adit A. Ginde, et al.. (2023). Consistent Effects of Early Remdesivir on Symptoms and Disease Progression Across At-Risk Outpatient Subgroups: Treatment Effect Heterogeneity in PINETREE Study. Infectious Diseases and Therapy. 12(4). 1189–1203. 8 indexed citations

Humeniuk, Rita, Anita Mathias, Brian J. Kirby, et al.. (2021). Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor. Clinical Pharmacokinetics. 60(5). 569–583. 93 indexed citations

Chaturvedi, Nimisha, Evguenia S. Svarovskaia, Hongmei Mo, et al.. (2019). Adaptation of hepatitis C virus to interferon lambda polymorphism across multiple viral genotypes. eLife. 8. 11 indexed citations

Shrivastava, Shikha, Sara Romani, Rebecca Lee, et al.. (2018). Multitarget Direct‐Acting Antiviral Therapy Is Associated With Superior Immunologic Recovery in Patients Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus. Hepatology Communications. 2(12). 1451–1466. 19 indexed citations

10.

Petersen, Tess, Y.-J. Lee, Anu Osinusi, et al.. (2016). Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin. AIDS Research and Human Retroviruses. 32(7). 660–667. 7 indexed citations

11.

Townsend, Kerry, Eric G. Meissner, Sreetha Sidharthan, et al.. (2015). Interferon-Free Treatment of Hepatitis C Virus in HIV/Hepatitis C Virus-Coinfected Subjects Results in Increased Serum Low-Density Lipoprotein Concentration. AIDS Research and Human Retroviruses. 32(5). 456–462. 28 indexed citations

12.

Petersen, Tess, Kerry Townsend, Sreetha Sidharthan, et al.. (2015). High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study. Hepatology International. 10(2). 310–319. 50 indexed citations

13.

Barrett, Lisa Feldman, Anu Osinusi, Anita Kohli, et al.. (2013). 1 ALTERED HCV SPECIFIC T CELL IMMUNITY VERY EARLY IN INTERFERON FREE HCV DAA THERAPY. Journal of Hepatology. 58. S1–S1. 13 indexed citations

14.

Katsounas, Antonios, Jonathan J. Hubbard, Xiaozhen Zhang, et al.. (2013). High interferon‐stimulated gene ISG‐15 expression affects HCV treatment outcome in patients co‐infected with HIV and HCV. Journal of Medical Virology. 85(6). 959–963. 12 indexed citations

15.

Silver, Daniel P., Anu Osinusi, Rachel Silk, et al.. (2013). Effect of HIV on Liver Fibrosis Among HCV-Infected African Americans. Clinical Infectious Diseases. 56(9). 1280–1283. 7 indexed citations

16.

Naggie, Susanna, Anu Osinusi, Antonios Katsounas, et al.. (2012). Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B -unfavorable genotype patients: Impaired viral kinetics and therapeutic response. Hepatology. 56(2). 444–454. 55 indexed citations

17.

Osinusi, Anu, Susanna Naggie, Seerat Poonia, et al.. (2012). ITPA gene polymorphisms significantly affect hemoglobin decline and treatment outcomes in patients coinfected with HIV and HCV. Journal of Medical Virology. 84(7). 1106–1114. 12 indexed citations

18.

Murphy, Alison, Eva Herrmann, Anu Osinusi, et al.. (2011). Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy. AIDS. 25(9). 1179–1187. 13 indexed citations

19.

Osinusi, Anu, Antonios Katsounas, Richard A. Lempicki, et al.. (2011). 1334 DYSREGULATION OF HOST INNATE IMMUNITY IN HCV GENOTYPE 1 INFECTED IL28B CT/TT HAPLOTYPE PATIENTS WITH DEPRESSED VIRAL KINETICS AND THERAPEUTIC RESPONSE. Journal of Hepatology. 54. S526–S527. 2 indexed citations

20.

Osinusi, Anu, David E. Kleiner, Bradford J. Wood, et al.. (2009). Rapid Development of Advanced Liver Fibrosis after Acquisition of Hepatitis C Infection during Primary HIV Infection. AIDS Patient Care and STDs. 23(6). 403–406. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact